Rozich v. Abbott Laboratories et al
| Francis M. Rozich |
| NOVARTIS CONSUMER HEALTH INC., ABBOTT LABORATORIES, TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA DEVELOPMENT CENTER AMERICAS INC. F/K/A TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER INC, NOVARTIS CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS INC., NOVARTIS PHARMACEUTICALS CORPORATION, GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC, TAKEDA PHARMACEUTICALS LLC, NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC., GLAXOSMITHKLINE CONSUMER HEALTHCARE LP, GlaxoSmithKline Consumer Healthcare Holdings (US) IP LLC, TAKEDA PHARMACEUTICALS U.S.A, INC. and TAKEDA PHARMACEUTICALS AMERICA INC. |
| PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION (No. II) |
| 2:2021cv00255 |
| January 6, 2021 |
| US District Court for the District of New Jersey |
| Claire C Cecchi |
| Mark Falk |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28:1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 6, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Member Case Transferred in on 1/6/21 from the Northern District of Illinois 1:20-cv-07567, for MDL 2789 Party PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION (No. II) added. (gh, ) |
| For all Case Management Orders #click here (gh, ) |
| Filing 11 Clerk's Notice to Counsel. (gh, ) |
| Judge Claire C. Cecchi and Chief Mag. Judge Mark Falk added. (gh, ) |
| Filing 10 Certified Copy of Transfer Order and docket received, Case transferred in from District of Illinois Northern; Case Number 1:20-cv-07567. Original file certified copy of transfer order and docket sheet received. |
| Filing 9 TRANSFERRED to the USDC New Jersey, Newark Division the Electronic Record. (rc, ) |
| ***Civil Case Terminated. (rc, ) |
| Filing 8 CONDITIONAL TRANSFER ORDER from MDL Panel transferring case to United States District Court for the District of New Jersey. Mailed notice (rc, ) |
| Filing 7 MINUTE entry before the Honorable John Z. Lee:A Rule 16 status hearing set for 2/10/21 at 8:45 a.m.The parties are directed to file a joint initial status report by 2/4/21. The report should comply with the requirements for initial joint status reports set forth in the Initial Status Conference standing order, which can be found on the Court's website. In light of the COVID-19 pandemic and the related General Orders, the Court finds that it is necessary to conduct the status hearing via telephone conference. The call-in number is 888-273-3658 and the access code is 1637578. Counsel of record will receive a separate email at least 12 hours prior to the start of the telephonic hearing with instructions on how to join the call. All persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in court-imposed sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. All participants should review the Court's standing order regarding telephone conferences that is on Judge Lee's website, which can be found at: https://www.ilnd.uscourts.gov/judge-info.aspx?4Qf5zc8loCI5U7rfMP9DHw==Mailed notice (ca, ) |
| Filing 6 MAILED Notice of Removal letter to E. Samuel Geisler (daj, ) |
| CASE ASSIGNED to the Honorable John Z. Lee. Designated as Magistrate Judge the Honorable Maria Valdez. Case assignment: Random assignment. (cp, ) |
| Filing 5 ATTORNEY Appearance for Defendants Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. by Sherry Ann Knutson (Knutson, Sherry) |
| Filing 4 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. (Hemmings, James) |
| Filing 3 ATTORNEY Appearance for Defendants Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. by James R M Hemmings (Hemmings, James) |
| Filing 2 CIVIL Cover Sheet (Hemmings, James) |
| Filing 1 NOTICE of Removal from Circuit Court of Cook County, Illinois, case number (2019-L-005961) filed by Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. Filing fee $ 402, receipt number 0752-17760983. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Hemmings, James) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
